Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units 
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand 
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence 
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring 
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 
ROLLING MEADOWS, IL, March 14, 2018 -- OneLife Technologies Corp. (“OneLife” or the “Company”) (OTC PINK: OLMM), a mobile medical data and technologies company, today announced that on March 8, 2018, it was made aware by OTC Markets of promotional activities surrounding the Company's common stock.
The Company immediately initiated an internal investigation into this matter and made inquiries of its executive officers, directors, controlling shareholders (i.e., shareholders owning 10% or more of the Company's securities, of which there is one (1)) and third-party service providers. The Company has made direct inquiries of its executive officers, directors, its controlling shareholders and its third-party service providers. As per their responses, none of the Company, nor its executive officers, directors or, its controlling shareholders nor third-party services providers have been involved in any way with the creation or distribution of promotional materials or activities.
Additionally, neither the Company’s executive officers, directors nor, to the knowledge of the Company, any controlling shareholders or any third-party service providers, has sold or purchased shares of common stock of the Company in the public market within the last 90 days.
Furthermore, the Company has not, other than disclosed in its periodic reports filed with the Securities and Exchange Commission, issued any shares or convertible instruments’ allowing conversion to equity securities at prices constituting a discount to the current market rate at the time of the issuance.
OneLife Technologies Corp. encourages those interested in the Company to rely solely on information included in its press releases combined with its filings and disclosures made with the Securities and Exchange Commission.
“Our internal investigation regarding the recent unsanctioned promotional activities remains ongoing,” stated Robert Wagner, CEO of OneLife Technologies, Corp. “In the meantime, we remain excited and extremely committed to the execution of our business plan, and we are looking forward to providing updates to our shareholders and the investment community in the near future,” added Wagner.
ABOUT ONELIFE TECHNOLOGIES CORP.
OneLife Technologies Corp. (OTC Pink: OLMM), is a mobile medical software/data collection company with a suite of proprietary, patented, medical grade wearable tracking technologies designed to provide patients, physicians, nursing homes, and hospitals with 24/7 real-time centralized, personal, comprehensive health data. The Company files periodic reports with the Securities and Exchange Commission, which can be viewed at www.sec.gov. For more information, visit: www.onelifetc.com
Contact: Robert J. Wagner President & CEO OneLife Technologies Corporation Phone: (708) 469-7378 Email: [email protected]
